Cytek Biosciences, Inc. (CTKB) stock
CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.92+0.22 (+3.86%)
Close on Nov 18, 2026Market cap $769.50MP/E –Yield –
Cytek Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cytek Biosciences's market cap was $748.70M on Nov 11, 2026, against $722.44M a year earlier. Over the last 5 years it ranged from $353.45M to $2.18B, with a median of $796.79M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $748.70M | +15.9% |
| 2025 | Dec 31, 2025 | $645.72M | -23.3% |
| 2024 | Dec 31, 2024 | $842.18M | -31.9% |
| 2023 | Dec 29, 2023 | $1.24B | -10.2% |
| 2022 | Dec 30, 2022 | $1.38B | -36.9% |
| 2021 | Dec 31, 2021 | $2.18B | – |
See a number that looks wrong?